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Available online 11 January 2016Background: Coronary heart disease (CHD) death rates have fallen across most of Europe in recent
decades. However, substantial risk factor reductions have not been achieved across all Europe. Our aim was to
quantify the potential impact of future policy scenarios on diet and lifestyle on CHD mortality in 9 European
countries.
Methods:Weupdated the previously validated IMPACT CHDmodels in 9 European countries and extended them
to 2010–11 (the baseline year) to predict reductions in CHDmortality to 2020(ages 25–74 years). We compared
three scenarios: conservative, intermediate and optimistic on smoking prevalence (absolute decreases of 5%, 10%
and 15%); saturated fat intake (1%, 2% and 3% absolute decreases in % energy intake, replaced by unsaturated
fats); salt (relative decreases of 10%, 20% and 30%), and physical inactivity (absolute decreases of 5%, 10% and
15%). Probabilistic sensitivity analyses were conducted.
Results: Under the conservative, intermediate and optimistic scenarios, we estimated 10.8% (95% CI: 7.3–14.0),
20.7% (95% CI: 15.6–25.2) and 29.1% (95% CI: 22.6–35.0) fewer CHD deaths in 2020. For the optimistic scenario,
15% absolute reductions in smoking could decrease CHD deaths by 8.9%–11.6%, Salt intake relative reductions of
30% by approximately 5.9–8.9%; 3% reductions in saturated fat intake by 6.3–7.5%, and 15% absolute increases in
physical activity by 3.7–5.3%.Keywords:
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287M. O'Flaherty et al. / International Journal of Cardiology 207 (2016) 286–291Conclusions:Modest and feasible policy-based reductions in cardiovascular risk factors (already been achieved in
some other countries) could translate into substantial reductions in future CHD deaths across Europe. However,
thiswould require the EuropeanUnion tomore effectively implement powerful evidence-based prevention policies.
© 2016 Elsevier Ireland Ltd. All rights reserved.Fig. 1. Structure of updated IMPACT CHD model.1. Introduction
Cardiovascular disease (CVD), particularly coronary heart disease
(CHD), continues to be a significant health problem in Europe and
globally. Despite a sustained decline in premature CVD morbidity and
mortality over two decades, this continuing burden will exert signifi-
cant pressure on future healthcare systems, particularly given the
sustained population ageing that most European countries are
experiencing [1]. Prevention of CVD is therefore still a high priority, as
recently stressed by the World Health Assembly [2].
Poor diet, tobacco, alcohol and physical inactivity are recognized as
key drivers of the CVD epidemic [3,4]. Furthermore structural, popula-
tion wide policies can achieve substantial improvements resulting in
large and rapid reductions in mortality [5] while also being cost-
saving, making them attractive from a public health perspective [6,7].
Some countries across the European region are therefore actively
promoting their own nutritional, physical activity and tobacco control
policies. However, the picture is mixed and many of the actions are
limited, focusing on health promotion and education rather than the
more powerful taxation and regulatory policy options [8]. Still, these
latter strategies are perceived as politically more challenging to
implement and their potential benefits are thus often overlooked.
The aim of this study was therefore to assess the number of deaths
from CHD preventable by a range of population wide structural inter-
ventions. These aimed tomodify themain lifestyle-related cardiovascu-
lar risk factors (smoking, salt and saturated fat intake and physical
activity level) in nine European countries participating in the EuroHeart
II project (Czech Republic, Finland, Iceland, Italy, Republic of Ireland,
Northern Ireland, Poland, Scotland, Sweden).
2. Methods
To forecast the number of deaths potentially preventable in 2020 we adapted original
IMPACT CHD Models in each country [9–19]. The data that the IMPACT model used to
translate changes in risk factors (systolic blood pressure, total cholesterol, physical activity
and smoking) intomortality reductions are detailed in the Technical Appendix (A2.1–2.4),
and description of the general modelling methods is available in previous publications
[20]. The original model estimates the deaths prevented or postponed (DPPs) that may
be attributable to specific risk factor changes or treatment changes over a period of time.
Here we summarize the methodology used to extend the IMPACT model to explore
further policies around changes in specific nutrients (salt and saturated fat intakes) and
perform forecasts of future mortality to 2020.
2.1. Estimating future trends in CHD mortality to 2020
In order to estimate future CHD mortality in 2020 for each country, an exponential
decay model was fitted using Matlab. This took account of historical CHD mortality rates
(annual trends by 10 year age group (from ages 25–74) and sex in each country. Annual
trend data on CHD mortality was available over a period varying between 17 and
26 years for each country i.e. from the 1980s or 1990s up to the year 2010–11). Official
population projections were obtained from national statistics agencies for the year 2020.
This allowed us to capture both change in population structure and ongoing change in
risk of mortality. This may therefore be a more realistic future mortality scenario
compared to the traditional indirect standardization method that only captures popula-
tion demographic changes, and simplistically assumes that CHD risk will remain constant
at baseline levels. CHD mortality trends and population projections were obtained from
national statistical offices in each country. For comparison, our analysis presented both
the exponential decay model counterfactual (“continuing decline in mortality”) and the
indirect standardized one (“no change in mortality”).
2.2. Updated IMPACT CHD model: translating changes in salt and saturated fat intake into
mortality reductions
Using dichotomous risk factor values, the impact of future levels of physical inactivity
and smoking on CHD mortality to 2020 was quantified using a population attributable
change based method, as in previous work [20].The original IMPACT model had no functionality to calculate deaths prevented or
postponed (DPPs) according to changes in salt consumption and saturated/unsaturated
fatty acids intake. For this project, we adapted the national IMPACT models by creating
two additional layers to translate the effects of changes in these risk factors to changes
in blood pressure and total cholesterol levels, as previously developed for analysis in the
UK and Ireland [21–23]. Translating the effect of salt intake variation to changes in blood
pressure was based on data published in a Cochrane systematic review [24] which
quantified the effect of salt reduction on bloodpressure inhypertensive and normotensive
patients. We then used conventional IMPACT modelling methodology to translate the
change in SBP levels into mortality reductions (see A2.1). In order to model the effect of
saturated fat intake on serum cholesterol levels, we used the Clarke equations [25] to
translate a change in saturated fat intake into a change in total cholesterol levels, assuming
iso-caloric replacement with polyunsaturated and mono-saturated fats (assuming that
each 1% absolute reduction in energy from saturated fat was replaced by 0.1% energy
from mono- and 0.9% energy from poly-unsaturated fats). We estimated the effect of
changes in multiple risk factors using a multiplicative approach, based on the methods
used by Bajekal et al. [20].
The structure of the updated model is presented on Fig. 1.2.3. Policy scenarios
Three policy scenarios were modelled to quantify the impact of potential future
changes in risk factors on future CHDmortality. The first (S1), most conservative scenario
assumed a small decrease in energy from saturated fats (and replacing itwith energy from
mono- and polyunsaturates), a modest 10% decrease in current salt intake, and a 5%
decrease in the prevalence of smokers and physically inactive people.
The most optimistic scenario (S3) assumed improvements already achieved in
exemplar countries. A salt intake reduction of 30% (as in Finland and Japan) [26,27]; a
15% decrease in the prevalence of smoking (Australia and California) [28,29] and 15%
decline in physical in activity (Finland, Cuba) [30,31]; and an absolute decrease of 5% in
energy from saturated fats (Finland [32]).
Finally, the intermediate and plausible scenario (S2) used reductions between the
conservative and optimistic ones, and its feasibility taking into account the baseline levels
of the behavioural and biological risk factors are presented in the appending (Table A1.1
and A1.2, Technical Appendix).
Finally, we estimated the maximum theoretical reductions in CHD mortality to 2020
achievable in each country with “optimal” risk factor profiles for both smoking (assuming
no-one in the country ever smoked) and physical inactivity (no inactive individuals).2.4. Sensitivity analysis
We quantified the degree of stochastic uncertainty using Monte Carlo simulation
implemented with R software. We repeated random draws from specified distributions
for the input variables to iteratively recalculate the model. We calculated the uncertainty
intervals based on 10,000 draws taking the 95% uncertainty intervals as the 2.5th and
97.5th percentiles. Input variables taken from external sources (e.g. beta coefficients and
relative risk reductions) were randomly drawn from specified distributions. Distributions
used for main input parameters are listed in the Technical Appendix (Table A3).
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In 2020, in all studied populations we expect approximately 63,800
(56,100–71,500) deaths assuming no changes in future mortality or
just 37,900 (31,900–44,200) deaths if current trends continue to
decline (Table 1, detailed mortality projections results are presented
in Table A4).
For the most conservative scenario the forecast decrease in the
expected number of deaths was 10.8% (7.3–14.0). Corresponding
reductions for the intermediate and optimistic scenarios were 20.7%
(15.6–25.2) and 29.1% (22.6–35.0) respectively. The forecast reductions
in the number of deaths prevented or postponed (DPPs) varied between
different countries (Table 2). For most optimistic scenario, relative
decrease in deaths ranged from 27.2% (15.3–40.6) in Finland to 31.7%
(16.5–48.9) for Sweden.
The absolute number of deaths prevented or postponed (DPPs)
depended on the futuremortality assumption. Assuming a continuation
of current decreasing mortality trends, the absolute number of DPPs in
all countries was estimated as approximately 4080 (2760–5290), 7830
(5900–9550) and 11,050 (8550–13,260) for the conservative, interme-
diate and optimistic scenarios respectively. If mortality did not decline,
these forecast numbers of deaths prevented of postponed would
be significantly higher: approximately 6900 (4820–8720), 13,240
(10,340–15,650) and 18,670 (14,990–21,800) respectively for the
three scenarios. The absolute benefits differ between countries
reflecting baseline mortality rates and population sizes (Table 2).
Nutrition-related policies resulting in reductions in salt and
saturated fats and tobacco policies would deliver the largest gains.
Together, they would account for approximately 80% of the reduction
in expected future coronary heartmortality in these European countries
(Fig. 2).
These gains from nutrition related policies occurred despite rather
moderate reductions in modelled systolic blood pressure and total
cholesterol values. The optimistic scenario for change in SBP across
the different countries ranged from 1.9 to 3.0 mm Hg. The correspond-
ing decrease in mean total cholesterol level was only 0.22 mmol/L.
The potential gains for the range of three policy scenarios were rela-
tively consistent across the nine diverse European countries (see Fig. 2
and Appendix , Table A5.1–4). This is expected since the proportional
reductions were the same in each country.
However, Fig. 3 presents the maximum possible fall in DPPs from
reductions in smoking and physical inactivity prevalence in each of
the 9 countries. This demonstrated the amount of mortality fall theoret-
ically possible if optimal levels of these risk factors could be achieved—
idealistically assuming no-one smokes in the population and that
there are no physically inactive individuals in any country. Countries
where risk factor levels and mortality remain high (such as
Scotland and Northern Ireland) have the greatest potential for
future benefit from population wide policies to reduce these major
risk factors.Table 1
Population and mortality projections (to 2020) for the EHII countries (adults 25–74 years).
Country Population
in base year
[million]
Population in
2020 (forecast)
[million]
Mortality in
base year
(per 100 000)
Mortality in
2020 (forecast
(per 100 000)
Czech 6.8 7.3 145 67
Finland 3.3 3.5 113 58
Iceland 0.2 0.2 55 34
Ireland 2.7 3.6 74 52
Italy 38.6 38.0 40 27
Northern Ireland 1.1 1.2 83 39
Poland 25.1 25.6 91 56
Scotland 3.3 3.5 98 52
Sweden 5.8 6.3 59 374. Discussion
Feasible reductions in the main dietary and lifestyle risk factors in
the nine studied EU countries could decrease future CHD mortality in
2020 and 2030 by approximately one third. The biggest gain would
come from dietary improvements followed by decreases in smoking
and physical inactivity. The results were reassuringly robust in the
sensitivity analyses, and reasonably consistent across the 9 European
populations included. These four lifestyle changes would therefore
appear likely to meet theWHONCD targets for a 25% relative reduction
in the risk of premature mortality from CVD by 2025 from 2010 levels.
The risk factor changes wemodelledwere similar to those recommend-
ed by the NCD targets; albeit slightly higher for reductions in physical
inactivity and slightly lower for reductions in smoking. However, our
analyses demonstrate the importance of changes in fat intake; which
account for about one-quarter of the estimated reductions. This nutrient
was not explicitly included as part of the WHO NCD targets; we
recommend it should be included in the next revision of these targets
and in all country targets for CHD prevention.
4.1. Comparison with other modelling studies
Our results are reassuringly consistent with results from other
studies. A recent analysis in Ireland [22] predicted some 1070 fewer
CHD and stroke deaths per year through healthier dietary intakes
(specifically, increasing fruit and vegetable intake by 3 portions/day
and reducing dietary salt by 3 g/day, trans-fats by 1% of total energy
intake and saturated fats by 3% of total energy intake).
A previous UK study using a different modelling methodology
suggested that feasible dietary improvementsmight reduce CVD deaths
by approximately 20% [33], consistent with our estimates. This involved
scenarios targeting a wider range of dietary risk factors (fruit and
vegetables, fibre, total fat, saturated fat, monounsaturated fatty acids,
polyunsaturated fatty acids, cholesterol and salt). The Global Burden
of Disease study recently suggested that modest improvements in six
dietary factors could achieve substantial reductions in the CVD burden
by 2025 [34].
4.2. Strengths & limitations
Our study has several strengths. Thismodelling approach is compre-
hensive yet conceptually simple. It explores the potential impact of
changes in major behavioural risk factors attributable to structural
policies across a diverse range of European countries. It thus offers
both regional and national level perspectives. We used the best avail-
able evidence from high quality nutritional survey data and systematic
reviews of effect sizes to inform key model parameters. Estimating
future mortality is highly uncertain, as shown by the rapid changes in
mortality rates in Central Europe and Russia. Our model therefore uses
a novel mortality counterfactual approach to explore a potential range)
No of deaths observed
in base year
[thousands]
Expected no of
deaths in 2020
(exponential decay model)
Expected no of
deaths in 2020
(no mortality change)
9.9 4.9 (2.1–8.3) 10.6 (5.6–15.7)
3.8 2.2 (1.5–3.1) 4.4 (3.5–5.3)
0.1 0.1 (0.1–0.1) 0.1 (0.1–0.1)
2.0 1.5 (1.1–1.9) 2.1 (1.7–2.6)
15.6 11 (7.2–15.2) 16.2 (13–19.5)
0.9 0.4 (0.3–0.5) 0.9 (0.7–1.1)
22.8 13.6 (10.7–16.6) 22.2 (17.8–26.7)
3.2 1.8 (1.2–2.4) 3.4 (2.7–4)
3.4 2.4 (1.4–3.4) 3.8 (3.2–4.4)
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Fig. 2. Percentage of total modelled CHD mortality reduction contributed by each policy
(for “Conservative” scenario).
289M. O'Flaherty et al. / International Journal of Cardiology 207 (2016) 286–291of contrasting future baseline mortality scenarios, to help quantify
where prevention could have the biggest impact on reducing future
CHD mortality.
Our study also has some limitations. Themodelling approach did not
quantify competing risks for mortality. However, this effect was partly
captured by the regression based mortality counterfactual, projecting
current observed CHD mortality trends and population demographic
projections. The risk factor effects were considered to be independent
and additive. This might have overestimated the total reductions in
mortality, despite our cumulative risk adjustment. Furthermore, the
model included only CHD mortality outcomes. Reducing these risk
factors would also have substantial benefits beyond coronary heart
disease, by also decreasing stroke, common cancers, and cognitive
decline [35,36], suggesting that we have underestimated the impact of
these changes on all cause mortality.
4.3. Public health implications
Our study demonstrates that moderate reductions in key life style
behaviours would have a large impact on future CHD mortality and
burden. However, recent trends in key risk factors across Europe have
been less favourable than in earlier decades [37]. These changes in
behaviours may thus not be achievable through education alone, but
require fiscal and legislative responses i.e. further development of
public health policy. This study forms part of the wider EU funded
EuroHeart II Project (http://www.ehnheart.org/euroheart-ii.html).
This has highlighted the fact that Central and Western European coun-
tries are at very different stages of developing public health policies to
promote healthy diet and lifestyle strategies. For example, health educa-
tion activities, dialogue, recommendations, guidelines, and patient
information campaigns are widespread. They represent an early and
uncontroversial part of the prevention policy process, but are consid-
ered to be only modestly effective. Conversely, taxation or regulation,
are generally seen asmore powerful strategies; but they remain uncom-
mon, probably because they are considered politicallymore challengingFig. 3. Reductions in mortality by country attributable to maximum theoretical
improvements in physical inactivity and smoking (to achieve 0% prevalence).
290 M. O'Flaherty et al. / International Journal of Cardiology 207 (2016) 286–291[8,38]. Specific regulations on salt, sugar and total fat are not wide-
spread. Public health nutrition policies in Europe represent a complex,
dynamic and rapidly changing environment. It is thus encouraging
that the majority of European countries are engaged energetically in
activities to improve their public health nutrition. However, most
countries fall well short of optimal activities. Furthermore, our results
highlight the potential opportunity costs of relying on less effective pol-
icies that rely on individual agency of healthcare providers and patients,
like increasing the uptake of healthcare based interventions for primary
prevention. Such downstream policies can achieve only small improve-
ments in diet and smoking in the population as a whole, and risk
widening inequalities [39]. Implementation of potentially powerful,
“upstream” nutrition policies such as fiscal and regulatory interventions
remains underused across Europe. A recent analysis from the Australian
cost-effectiveness analysis programme (ACE) demonstrated that man-
datory limits on salt in processed foods (particularly bread, margarine
and cereals, resulting in reduction of 3–4 g a day of salt intake) would
be the most cost-effective way of preventing premature CVD [40]. It
also pointed out that current practise in the UK, Australian and else-
where was inefficient, ignoring the most cost-effective policies and
implementing policies (such as dietary advice or vascular health checks
in primary care) which are not effective and have little population
health benefits [40]. The scenarios modelled in our study also illustrate
the potential benefits of structural policieswith populationwide effects,
and in the case of smoking and physical activities, maximum possible
gains by moving the entire population to a healthier lifestyle. Thus the
biggest mortality gains could only be delivered if those risk factors
were substantially reduced by regulation introducing or increasing
taxation of salt and fat and tobacco [21,41]. However, such policies sit
higher up on the Nuffield ‘ladder of interventions’ [42]. Furthermore,
the current direction of a major European wide policy initiative, the
Transatlantic Trade Treaty, may pose a powerful threat to such policies
[43]. The treaty negotiations are currently focused on protecting corpo-
rate interests while also undermining the power of states to regulate
effective structural dietary and lifestyle policies [44]. The current EU
diet and lifestyle policy environment is thus not particularly challenging
or optimal at present, given that most of the current activity is not
taxation or regulation but voluntary agreements with industry or
individual level and educational interventions.
Our analyses highlight opportunities for massive health gains,
and possibly still accruing after the time horizon in our analysis.
However, this will need active policy engagement in identifying and
implementing structural interventions. Although improvements in
diet can rapidly translate into mortality reductions, these can also be
quickly reversed [5,31,37]. Our modelled policy scenarios are politically
feasible, and might be cautiously generalizable to other countries in
Europe. They illustrate how successful policies in one country might
translate into benefitswhen explored in a different setting. For example,
government led reformulation policies in the UK, from 2003 to 2011,
have resulted in salt reductions of about 1.5 g/day a (15% reduction,
consistent with our optimistic scenario). Our modelling platform
might therefore be potentially useful as a tool for prioritization and for
supporting national and European debate on food policy.
4.4. Conclusions
Substantial reductions in coronary mortality could be gained by
eminently feasible risk factor reductions achievable through population-
wide diet and tobacco policies. These cost saving public health strategies
should now be prioritized during the current debates shaping the future
of healthy EU food policies.
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